{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:13:49Z","timestamp":1760228029971,"version":"build-2065373602"},"reference-count":68,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2, SARS2) remains a great global health threat and demands identification of more effective and SARS2-targeted antiviral drugs, even with successful development of anti-SARS2 vaccines. Viral replicons have proven to be a rapid, safe, and readily scalable platform for high-throughput screening, identification, and evaluation of antiviral drugs against positive-stranded RNA viruses. In the study, we report a unique robust HIV long terminal repeat (LTR)\/T7 dual-promoter-driven and dual-reporter firefly luciferase (fLuc) and green fluorescent protein (GFP)-expressing SARS2 replicon. The genomic organization of the replicon was designed with quite a few features that were to ensure the replication fidelity of the replicon, to maximize the expression of the full-length replicon, and to offer the monitoring flexibility of the replicon replication. We showed the success of the construction of the replicon and expression of reporter genes fLuc and GFP and SARS structural N from the replicon DNA or the RNA that was in vitro transcribed from the replicon DNA. We also showed detection of the negative-stranded genomic RNA (gRNA) and subgenomic RNA (sgRNA) intermediates, a hallmark of replication of positive-stranded RNA viruses from the replicon. Lastly, we showed that expression of the reporter genes, N gene, gRNA, and sgRNA from the replicon was sensitive to inhibition by Remdesivir. Taken together, our results support use of the replicon for identification of anti-SARS2 drugs and development of new anti-SARS strategies targeted at the step of virus replication.<\/jats:p>","DOI":"10.3390\/v14050974","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T02:46:39Z","timestamp":1651805199000},"page":"974","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Unique Robust Dual-Promoter-Driven and Dual-Reporter-Expressing SARS-CoV-2 Replicon: Construction and Characterization"],"prefix":"10.3390","volume":"14","author":[{"given":"Ying","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Chicago Medical School, Rosalind Franklin University, North Chicago, IL 60064, USA"},{"name":"Center for Cancer Cell Biology, Immunology and Infection, Rosalind Franklin University, North Chicago, IL 60064, USA"},{"name":"School of Graduate and Postdoctoral Studies, Rosalind Franklin University, North Chicago, IL 60064, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Chicago Medical School, Rosalind Franklin University, North Chicago, IL 60064, USA"},{"name":"Center for Cancer Cell Biology, Immunology and Infection, Rosalind Franklin University, North Chicago, IL 60064, USA"},{"name":"School of Graduate and Postdoctoral Studies, Rosalind Franklin University, North Chicago, IL 60064, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid A.","family":"Timani","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Chicago Medical School, Rosalind Franklin University, North Chicago, IL 60064, USA"},{"name":"Center for Cancer Cell Biology, Immunology and Infection, Rosalind Franklin University, North Chicago, IL 60064, USA"},{"name":"School of Graduate and Postdoctoral Studies, Rosalind Franklin University, North Chicago, IL 60064, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnny J.","family":"He","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Chicago Medical School, Rosalind Franklin University, North Chicago, IL 60064, USA"},{"name":"Center for Cancer Cell Biology, Immunology and Infection, Rosalind Franklin University, North Chicago, IL 60064, USA"},{"name":"School of Graduate and Postdoctoral Studies, Rosalind Franklin University, North Chicago, IL 60064, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12931-020-01338-8","article-title":"Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A retrospective analysis","volume":"21","author":"Zhang","year":"2020","journal-title":"Respir. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.46234\/ccdcw2020.017","article-title":"A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases\u2014Wuhan, China 2019\u20132020","volume":"2","author":"Tan","year":"2020","journal-title":"China CDC Wkly."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.jinf.2020.04.004","article-title":"CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China","volume":"81","author":"Meng","year":"2020","journal-title":"J. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"unstructured":"(2022, April 19). World Health Organization Coronavirus (COVID-19) Dashboard. Available online: http:\/\/COVID19.WHO.int.","key":"ref_5"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"114392","DOI":"10.1016\/j.jviromet.2021.114392","article-title":"The screening value of RT-LAMP and RT-PCR in the diagnosis of COVID-19: Systematic review and meta-analysis","volume":"300","author":"Pu","year":"2022","journal-title":"J. Virol. Methods"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ijd.15749","article-title":"COVID-19 skin lesions are rarely positive at RT-PCR test: The macrophage activation with vascular impact and SARS-CoV-2-induced cytokine storm","volume":"61","author":"Ionescu","year":"2022","journal-title":"Int. J. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ymthe.2022.02.016","article-title":"COVID-19 mRNA vaccines: Platforms and current developments","volume":"30","author":"Szabo","year":"2022","journal-title":"Mol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13337-022-00755-1","article-title":"A comprehensive review on COVID-19 vaccines: Development, effectiveness, adverse effects, distribution and challenges","volume":"33","author":"Rahman","year":"2022","journal-title":"Virusdisease"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"106700","DOI":"10.1016\/j.cct.2022.106700","article-title":"COVID-19 vaccines: Considering sex differences in efficacy and safety","volume":"115","author":"Jensen","year":"2022","journal-title":"Contemp. Clin. Trials"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11684-021-0893-y","article-title":"A review of the safety and efficacy of current COVID-19 vaccines","volume":"16","author":"Huang","year":"2022","journal-title":"Front. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2020.04.020","article-title":"Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza","volume":"181","author":"Abbott","year":"2020","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1038\/s41467-021-24577-9","article-title":"Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance","volume":"12","author":"Fareh","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00210-021-02169-0","article-title":"Association and pharmacological synergism of the triple drug therapy baricitinib\/remdesivir\/rhACE2 for the management of COVID-19 infection","volume":"395","author":"Vitiello","year":"2022","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/17460441.2021.1970743","article-title":"An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19)","volume":"17","author":"Pagliano","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"doi-asserted-by":"crossref","unstructured":"Kaka, A.S., MacDonald, R., Linskens, E.J., Langsetmo, L., Vela, K., Duan-Porter, W., and Wilt, T.J. (2022). Major Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points. Ann. Intern. Med.","key":"ref_17","DOI":"10.7326\/M21-4784"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s15010-021-01671-0","article-title":"Efficacy and safety of remdesivir in hospitalised COVID-19 patients: A systematic review and meta-analysis","volume":"50","author":"Angamo","year":"2022","journal-title":"Infection"},{"doi-asserted-by":"crossref","unstructured":"Pourkarim, F., Pourtaghi-Anvarian, S., and Rezaee, H. (2022). Molnupiravir: A new candidate for COVID-19 treatment. Pharmacol. Res. Perspect., 10.","key":"ref_19","DOI":"10.1002\/prp2.909"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2217\/fmb-2021-0252","article-title":"Comprehensive review on molnupiravir in COVID-19: A novel promising antiviral to combat the pandemic","volume":"17","author":"Khiali","year":"2022","journal-title":"Future Microbiol."},{"doi-asserted-by":"crossref","unstructured":"Thye, A.Y., Law, J.W., Tan, L.T., Pusparajah, P., Ser, H.L., Thurairajasingam, S., Letchumanan, V., and Lee, L.H. (2022). Psychological Symptoms in COVID-19 Patients: Insights into Pathophysiology and Risk Factors of Long COVID-19. Biology, 11.","key":"ref_21","DOI":"10.3390\/biology11010061"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40124-021-00260-x","article-title":"Long-Term Complications of COVID-19 Infection in Adolescents and Children","volume":"10","author":"Thallapureddy","year":"2022","journal-title":"Curr. Pediatr. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological sequelae of long-haul COVID","volume":"23","author":"Mehandru","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.mayocp.2021.12.017","article-title":"Long-Term Effects of COVID-19","volume":"97","author":"Joshee","year":"2022","journal-title":"Mayo Clin. Proc."},{"doi-asserted-by":"crossref","unstructured":"Han, Q., Zheng, B., Daines, L., and Sheikh, A. (2022). Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens, 11.","key":"ref_25","DOI":"10.3390\/pathogens11020269"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.00375.2021","article-title":"Long-term complications of COVID-19","volume":"322","author":"Desai","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","article-title":"The Architecture of SARS-CoV-2 Transcriptome","volume":"181","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/bs.aivir.2016.08.008","article-title":"The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing","volume":"96","author":"Snijder","year":"2016","journal-title":"Adv. Virus Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-virology-100114-055218","article-title":"Continuous and Discontinuous RNA Synthesis in Coronaviruses","volume":"2","author":"Sola","year":"2015","journal-title":"Annu. Rev. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1128\/jvi.62.5.1687-1696.1988","article-title":"Construction and characterization of poliovirus subgenomic replicons","volume":"62","author":"Kaplan","year":"1988","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1128\/JVI.76.12.6398-6407.2002","article-title":"Feline calicivirus: Recovery of wild-type and recombinant viruses after transfection of cRNA or cDNA constructs","volume":"76","author":"Thumfart","year":"2002","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/nbt1291-1356","article-title":"A new generation of animal cell expression vectors based on the Semliki Forest virus replicon","volume":"9","author":"Liljestrom","year":"1991","journal-title":"Biotechnology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/jvi.71.2.1497-1505.1997","article-title":"Subgenomic replicons of the flavivirus Kunjin: Construction and applications","volume":"71","author":"Khromykh","year":"1997","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line","volume":"285","author":"Lohmann","year":"1999","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1128\/JVI.72.3.2364-2372.1998","article-title":"Characterization of an autonomous subgenomic pestivirus RNA replicon","volume":"72","author":"Behrens","year":"1998","journal-title":"J. Virol."},{"doi-asserted-by":"crossref","unstructured":"Pang, X., Zhang, M., and Dayton, A.I. (2001). Development of Dengue virus type 2 replicons capable of prolonged expression in host cells. BMC Microbiol., 1.","key":"ref_36","DOI":"10.1186\/1471-2180-1-28"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/viro.2002.1453","article-title":"Construction and characterization of subgenomic replicons of New York strain of West Nile virus","volume":"296","author":"Shi","year":"2002","journal-title":"Virology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1099\/vir.0.80044-0","article-title":"Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA","volume":"85","author":"Hertzig","year":"2004","journal-title":"J. Gen. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.virol.2006.10.016","article-title":"Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening","volume":"360","author":"Ge","year":"2007","journal-title":"Virology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.antiviral.2008.05.005","article-title":"High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery","volume":"80","author":"Ge","year":"2008","journal-title":"Antivir. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"12683","DOI":"10.1128\/JVI.78.22.12683-12688.2004","article-title":"The nucleoprotein is required for efficient coronavirus genome replication","volume":"78","author":"Almazan","year":"2004","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbrc.2008.06.129","article-title":"Construction of a non-infectious SARS coronavirus replicon for application in drug screening and analysis of viral protein function","volume":"374","author":"Wang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nrd942","article-title":"Hepatitis C virus replicons: Potential role for drug development","volume":"1","author":"Bartenschlager","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00001432-200112000-00013","article-title":"Hepatitis C virus cell culture replication systems: Their potential use for the development of antiviral therapies","volume":"14","author":"Randall","year":"2001","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0092-8674(90)90120-4","article-title":"TAR-independent activation of the HIV-1 LTR: Evidence that tat requires specific regions of the promoter","volume":"62","author":"Berkhout","year":"1990","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/j.1460-2075.1990.tb08223.x","article-title":"Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C","volume":"9","author":"Jakobovits","year":"1990","journal-title":"EMBO J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"8291","DOI":"10.1073\/pnas.85.21.8291","article-title":"Transcriptional activation of homologous viral long terminal repeats by the human immunodeficiency virus type 1 or the human T-cell leukemia virus type I tat proteins occurs in the absence of de novo protein synthesis","volume":"85","author":"Jeang","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1101\/gad.3.4.547","article-title":"Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat","volume":"3","author":"Selby","year":"1989","journal-title":"Genes Dev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"109108","DOI":"10.1016\/j.celrep.2021.109108","article-title":"Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection","volume":"35","author":"Chang","year":"2021","journal-title":"Cell Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13073-020-00763-0","article-title":"Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein","volume":"12","author":"Davidson","year":"2020","journal-title":"Genome Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: Implications for SARS-CoV-2","volume":"19","author":"Kratzel","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.cell.2021.02.047","article-title":"The SARS-CoV-2 subgenome landscape and its novel regulatory features. Mol","volume":"81","author":"Wang","year":"2021","journal-title":"Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/molbev\/msaa281","article-title":"Characterizing Transcriptional Regulatory Sequences in Coronaviruses and Their Role in Recombination","volume":"38","author":"Yang","year":"2021","journal-title":"Mol. Biol. Evol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19\u2014Final Report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1074\/jbc.AC120.013056","article-title":"The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate Use of Remdesivir for Patients with Severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41467-020-20542-0","article-title":"Mechanism of SARS-CoV-2 polymerase stalling by remdesivir","volume":"12","author":"Kokic","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2020.05.034","article-title":"Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"doi-asserted-by":"crossref","unstructured":"Liu, S., Chou, C.K., Wu, W.W., Luan, B., and Wang, T.T. (2022). Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen. J. Virol., 96.","key":"ref_59","DOI":"10.1128\/jvi.02216-21"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1126\/science.abj8430","article-title":"Replication and single-cycle delivery of SARS-CoV-2 replicons","volume":"374","author":"Luna","year":"2021","journal-title":"Science"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"001583","DOI":"10.1099\/jgv.0.001583","article-title":"SARS-CoV-2 replicon for high-throughput antiviral screening","volume":"102","author":"Zhang","year":"2021","journal-title":"J. Gen. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41598-021-82055-0","article-title":"A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation","volume":"11","author":"Kotaki","year":"2021","journal-title":"Sci. Rep."},{"doi-asserted-by":"crossref","unstructured":"He, X., Quan, S., Xu, M., Rodriguez, S., Goh, S.L., Wei, J., Fridman, A., Koeplinger, K.A., Carroll, S.S., and Grobler, J.A. (2021). Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing. Proc. Natl. Acad. Sci. USA, 118.","key":"ref_63","DOI":"10.1073\/pnas.2025866118"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/jmv.27650","article-title":"Construction and characterization of two SARS-CoV-2 minigenome replicon systems","volume":"94","author":"Zhang","year":"2022","journal-title":"J. Med. Virol."},{"doi-asserted-by":"crossref","unstructured":"Nguyen, H.T., Falzarano, D., Gerdts, V., and Liu, Q. (2021). Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies. J. Virol., 95.","key":"ref_65","DOI":"10.1128\/JVI.00687-21"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s12250-021-00369-9","article-title":"Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation","volume":"36","author":"Wang","year":"2021","journal-title":"Virol. Sin."},{"doi-asserted-by":"crossref","unstructured":"Luo, Y., Yu, F., Zhou, M., Liu, Y., Xia, B., Zhang, X., Liu, J., Zhang, J., Du, Y., and Li, R. (2021). Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors. mBio, 12.","key":"ref_67","DOI":"10.1128\/mBio.02754-20"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"105268","DOI":"10.1016\/j.antiviral.2022.105268","article-title":"Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening","volume":"199","author":"Tanaka","year":"2022","journal-title":"Antivir. Res."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/5\/974\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:06:39Z","timestamp":1760137599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/5\/974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,5]]},"references-count":68,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["v14050974"],"URL":"https:\/\/doi.org\/10.3390\/v14050974","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2022,5,5]]}}}